Eye Health News and Research

Latest Eye Health News and Research

Optics Express publishes new paper on smart micromanipulation aided robotic-surgical tool

Even the most skilled and steady surgeons experience minute, almost imperceptible hand tremors when performing delicate tasks. Normally, these tiny motions are inconsequential, but for doctors specializing in fine-scale surgery, such as operating inside the human eye or repairing microscopic nerve fibers, freehand tremors can pose a serious risk for patients.

28 Sep 2012

Loyola offers corrective surgeries for adults with strabismus

Since she was a child, Katie Szymczak has had eyes that wandered. Her right eye, which was the worst, would look up and to the side, rather than straight ahead. Her husband affectionately called them "googly eyes." But other people could be mean. "They would say to me, 'What's wrong with your eyes, why aren't you looking at me?'" Szymczak said. "It really hurt a lot."

28 Sep 2012

Care Harbor to provide free medical, dental and vision services in L.A.

Today marked the start of the largest free healthcare clinic in the United States, organized by Care Harbor. In collaboration with L.A. Care Health Plan and Dignity Health, Care Harbor will provide free medical, dental and vision services to those in need beginning today through September 30.

28 Sep 2012

Leptin hormone may play a role in hearing and vision loss

Leptin - commonly dubbed the "fat hormone" - does more than tell the brain when to eat. A new study by researchers at The University of Akron and Northeast Ohio Medical University (NEOMED) shows that leptin may play a role in hearing and vision loss.

27 Sep 2012

Medicaid: Ark. Gov. pushes expansion, Maine hunts for savings

Arkansas's governor is trying to use the health law's Medicaid coverage expansion to prevent a GOP takeover of the state legislature, while Maine hunts for savings in its Medicaid program.

27 Sep 2012

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.

27 Sep 2012

Cost of glaucoma revealed

The first 6 months after an open-angle glaucoma diagnosis are the most costly within the first 2 years of having the condition, report US researchers.

26 Sep 2012

Universitat de València to use optical technology to prevent myopia

The Universitat de València will use optical technology in order to prevent myopia, which is considered the most common eye disease in the world. Until now, this technology was only used in astronomy to study images of the Universe.

26 Sep 2012

Dexamethasone use during tonsillectomy not associated with excessive bleeding in children

Tonsillectomy is exceedingly common, with a reported increase in tonsillectomy rates in children younger than 15 years from 287,000 to 530,000 per year over the past decade. Although safe, adenotonsillectomy can result in significant complications, such as aspiration and bleeding. Complications are infrequent, but because tonsillectomy is so common, the absolute number of children experiencing tonsillectomy complications is formidable.

26 Sep 2012

Health insurance costs rise, driven by higher hospital, doctor prices

According to a report by the Health Care Cost Institute, insurance spending jumped in 2011 - a departure from the two previous years.

26 Sep 2012

New technological tools automatically measure relevant behaviors of children with autism

Researchers in Georgia Tech's Center for Behavior Imaging have developed two new technological tools that automatically measure relevant behaviors of children, and promise to have significant impact on the understanding of behavioral disorders such as autism.

26 Sep 2012

STAAR Surgical to participate in 88th Congress of the Society of Spanish Ophthalmologists

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will be participating in the 88th Congress of the Society of Spanish Ophthalmologists being held in Barcelona from September 26 to 29.

26 Sep 2012

Increasing marijuana-like chemicals in the brain can help correct behavioral issues related to fragile X

American and European scientists have found that increasing natural marijuana-like chemicals in the brain can help correct behavioral issues related to fragile X syndrome, the most common known genetic cause of autism.

26 Sep 2012

First Edition: September 25, 2012

Today's headlines headlines include reports about a study that details accelerating health care spending.

25 Sep 2012

Lack of cytokeratin 6A may lead to eye infections

Exposed tissue surfaces, including skin and mucous membranes, are under constant threat of attack by microorganisms in the environment. The layer of cells that line these areas, known as epithelial cells, are the first line of defense against these pathogens, but the underlying molecular mechanisms that allow them to repel microbes are unknown.

25 Sep 2012

Tips for health care providers when communicating with deaf or hearing impaired

This week is the International Week of the Deaf, held to draw attention to deaf and hearing-impaired people, their accomplishments and challenges they face. One health care issue is a potential communication barrier between medical providers and deaf or hard-of-hearing patients.

25 Sep 2012

Small fragments of keratin protein in the eye play a key role in warding off pathogens

When it comes to germ-busting power, the eyes have it, according to a discovery by University of California, Berkeley, researchers that could lead to new, inexpensive antimicrobial drugs.

25 Sep 2012

New nanotechnology detects micrometastases in mouse models of breast cancer

Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.

25 Sep 2012

pSivida reports revenues of $699,000 for fourth quarter 2012

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its fourth quarter and fiscal year ended June 30, 2012.

25 Sep 2012